Prognostic usefulness of left ventricular hypertrophy by electrocardiography in patients with atrial fibrillation (from the Randomized Evaluation of Long-Term Anticoagulant Therapy Study).

PubWeight™: 0.76‹?›

🔗 View Article (PMID 24359765)

Published in Am J Cardiol on November 23, 2013

Authors

Paolo Verdecchia1, Gianpaolo Reboldi2, Giuseppe Di Pasquale3, Giovanni Mazzotta4, Giuseppe Ambrosio4, Sean Yang5, Janice Pogue5, Lars Wallentin6, Michael D Ezekowitz7, Stuart J Connolly5, Salim Yusuf5, RE-LY Study Investigators

Author Affiliations

1: Department of Medicine, Hospital of Assisi, Assisi, Italy. Electronic address: verdec@tin.it.
2: Department of Internal Medicine, University of Perugia, Perugia, Italy.
3: Department of Cardiology, Maggiore Hospital, Bologna, Italy.
4: Department of Cardiology and Cardiovascular Pathophysiology, University of Perugia, Perugia, Italy.
5: Population Health Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada.
6: Uppsala Clinical Research Center and Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
7: Jefferson Medical College, Wynnewood, Pennsylvania; Atrial Fibrillation Research and Education, Cardiovascular Research Foundation, New York, New York.

Associated clinical trials:

Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate | NCT00262600

Articles citing this

A Review of the Relationship of Atrial Fibrillation and Acute Coronary Syndrome. Curr Emerg Hosp Med Rep (2016) 0.75

Articles by these authors

Novel Approaches in Primary Cardiovascular Disease Prevention: The HOPE-3 Trial Rationale, Design, and Participants' Baseline Characteristics. Can J Cardiol (2015) 1.38

Echo and natriuretic peptide guided therapy improves outcome and reduces worsening renal function in systolic heart failure: An observational study of 1137 outpatients. Int J Cardiol (2016) 1.00

Food Consumption and its Impact on Cardiovascular Disease: Importance of Solutions Focused on the Globalized Food System: A Report From the Workshop Convened by the World Heart Federation. J Am Coll Cardiol (2015) 0.95

Variations in Diabetes Prevalence in Low-, Middle-, and High-Income Countries: Results From the Prospective Urban and Rural Epidemiological Study. Diabetes Care (2016) 0.84

Current presentation and management of 7148 patients with atrial fibrillation in cardiology and internal medicine hospital centers: the ATA AF study. Int J Cardiol (2012) 0.83

Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold? Am Heart J (2014) 0.83

Temporal trends in the epidemiology, management, and outcome of patients with cardiogenic shock complicating acute coronary syndromes. Eur J Heart Fail (2015) 0.81

Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial. Eur Heart J (2015) 0.79

Hyperglycemia in acute coronary syndromes: from mechanisms to prognostic implications. Ther Adv Cardiovasc Dis (2015) 0.79

Hospital readmissions of patients with heart failure: the impact of hospital and primary care organizational factors in Northern Italy. PLoS One (2015) 0.79

Association between the use of fondaparinux vs low-molecular-weight heparin and clinical outcomes in patients with non-ST-segment elevation myocardial infarction. JAMA (2015) 0.79

Contemporary Trends and Age-Specific Sex Differences in Management and Outcome for Patients With ST-Segment Elevation Myocardial Infarction. J Am Heart Assoc (2016) 0.79

Combining therapeutic hypothermia and emergent coronary angiography in out-of-hospital cardiac arrest survivors: Optimal post-arrest care for the best patient. Eur Heart J Acute Cardiovasc Care (2014) 0.78

How can we optimize the processes of care for acute coronary syndromes to improve outcomes? Am Heart J (2014) 0.78

Right ventricular recovery during follow-up is associated with improved survival in patients with chronic heart failure with reduced ejection fraction. Eur J Heart Fail (2016) 0.77

Effectiveness and outcome of management strategies for dabigatran- or warfarin-related major bleeding events. Thromb Res (2016) 0.76

Response to letter regarding article, "Management and outcomes of major bleeding during treatment with dabigatran or warfarin". Circulation (2014) 0.75

Echo and BNP serial assessment in ambulatory heart failure care: Data on loop diuretic use and renal function. Data Brief (2016) 0.75

Masked and White-Coat Hypertension: Moving to African Americans. J Am Coll Cardiol (2015) 0.75

Prognostic validation of a non-laboratory and a laboratory based cardiovascular disease risk score in multiple regions of the world. Heart (2017) 0.75

Recent trends in management and outcome of patients with acute coronary syndromes and atrial fibrillation. Int J Cardiol (2017) 0.75

A polypill for cardiovascular disease prevention with a focus on non-alcohol steatohepatitis. Eur Heart J (2022) 0.75

Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014. Eur Heart J (2017) 0.75

The SPRINT trial. J Am Soc Hypertens (2015) 0.75

Insulin Resistance and Cardiovascular Outcomes in the ORIGIN Trial. Diabetes Obes Metab (2017) 0.75

Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation- the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study. Europace (2017) 0.75

Antithrombotic prophylaxis of atrial fibrillation in an Italian real-world setting: a retrospective study. Vasc Health Risk Manag (2017) 0.75